Thrombopoietin Receptor Agonists in Treatment of Idiopathic Thrompocytopenic Purpura (Primary Immune Thrombocytopenia): Efficacy and Safety in Everyday Clinical Practice
Klinicheskaya Onkogematologiya/Clinical Oncohematology - Russian Federation
doi 10.21320/2500-2139-2017-10-1-93-100
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2017
Authors
Publisher
Practical Medicine Publishing House